Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors

NCT00304083 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Neurofibromatosis Type 1
Sarcoma

Interventions

BIOLOGICAL: filgrastim
DRUG: doxorubicin hydrochloride
DRUG: etoposide
DRUG: ifosfamide
PROCEDURE: conventional surgery
RADIATION: radiation therapy

Sponsor

Sarcoma Alliance for Research through Collaboration

Collaborators

[object Object]